PDF(Pubmed)
Abstract：
UNASSIGNED: Clinical research and epidemiological studies have shown that many women experience physical and behavioral symptoms that begin during the luteal phase of the menstrual cycle and terminate around the onset of menses; this is called premenstrual syndrome. The reviews stated that the pooled prevalence of premenstrual syndrome was around 50 percent. However, there has been no review done on premenstrual syndrome in Africa. Therefore, the aim of this systematic review and meta-analysis was to summarize the most recent data evidence on the pooled prevalence of premenstrual syndrome and its pooled effect of associated factors in Africa.
UNASSIGNED: We used an appropriate guideline for systematic reviews and meta-analyses reports, which is the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). This review protocol was registered in PROSPERO (CRD42023414021). The publications were identified from PubMed/Medline, EMBASE, Scopus databases, and other grey searches. The included papers were the original data that reported the prevalence of premenstrual syndrome and associated factors published, in English, and papers available online from January 1, 2000, to May 30, 2023. The data was extracted in Microsoft Excel, and then it would be imported into STATA 11.0 for analysis.
UNASSIGNED: We have included 16 studies conducted in African countries with 6530 study participants. In this meta-analysis, the pooled prevalence of premenstrual syndrome among the reproductive-age participants in Africa was 46.98 (95% CI: 28.9-65.06%). Further, in subgroup analysis, the pooled prevalence of premenstrual syndrome was 57.32% in Nigeria, 43.8% in Ethiopia, and 38.6% among university students and 66.04% among secondary school students. Among associated factors, the early age of menarche was significantly related to premenstrual syndrome.
UNASSIGNED: In this review, the pooled prevalence of premenstrual syndrome in Africa was high. Among factors, the early age of menarche was a risk factor for premenstrual syndrome. This finding might help the stakeholders (mental health policy makers, administrators, and mental health professionals) to address prevention, early screening, and management of PMS among reproductive-age women, and to give attention to more vulnerable bodies.
UNASSIGNED: https://www.crd.york.ac.uk/PROSPERO, identifier CRD42023414021.
UNASSIGNED: We used an appropriate guideline for systematic reviews and meta-analyses reports, which is the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). This review protocol was registered in PROSPERO (CRD42023414021). The publications were identified from PubMed/Medline, EMBASE, Scopus databases, and other grey searches. The included papers were the original data that reported the prevalence of premenstrual syndrome and associated factors published, in English, and papers available online from January 1, 2000, to May 30, 2023. The data was extracted in Microsoft Excel, and then it would be imported into STATA 11.0 for analysis.
UNASSIGNED: We have included 16 studies conducted in African countries with 6530 study participants. In this meta-analysis, the pooled prevalence of premenstrual syndrome among the reproductive-age participants in Africa was 46.98 (95% CI: 28.9-65.06%). Further, in subgroup analysis, the pooled prevalence of premenstrual syndrome was 57.32% in Nigeria, 43.8% in Ethiopia, and 38.6% among university students and 66.04% among secondary school students. Among associated factors, the early age of menarche was significantly related to premenstrual syndrome.
UNASSIGNED: In this review, the pooled prevalence of premenstrual syndrome in Africa was high. Among factors, the early age of menarche was a risk factor for premenstrual syndrome. This finding might help the stakeholders (mental health policy makers, administrators, and mental health professionals) to address prevention, early screening, and management of PMS among reproductive-age women, and to give attention to more vulnerable bodies.
UNASSIGNED: https://www.crd.york.ac.uk/PROSPERO, identifier CRD42023414021.
摘要：
■临床研究和流行病学研究表明，许多女性在月经周期的黄体期出现身体和行为症状，并在月经开始时终止；这被称为经前期综合征。评论指出，经前期综合征的合并患病率约为50％。然而,尚未对非洲的经前综合征进行审查.因此,本系统综述和荟萃分析的目的是总结非洲经前期综合征汇总患病率及其相关因素汇总效应的最新数据证据.
■我们对系统评价和荟萃分析报告使用了适当的指南，这是系统审查和荟萃分析(PRISMA)的首选报告项目。本综述方案在PROSPERO(CRD42023414021)中注册。出版物来自PubMed/Medline，EMBASE,Scopus数据库,和其他灰色搜索。纳入的论文是报告经前综合征患病率和相关因素发表的原始数据，在英语中,和论文可从2000年1月1日至2023年5月30日在线获得。数据是在MicrosoftExcel中提取的，然后将其导入到STATA11.0中进行分析。
■我们纳入了在非洲国家进行的16项研究，有6530名研究参与者。在这个荟萃分析中，非洲育龄期参与者的经前期综合征合并患病率为46.98(95%CI:28.9~65.06%).Further,在亚组分析中，尼日利亚经前期综合征的合并患病率为57.32%，埃塞俄比亚占43.8%，大学生为38.6%，中学生为66.04%。在相关因素中，初潮年龄较早与经前期综合征显著相关。
■在这篇评论中，非洲经前期综合征的合并患病率较高.在因素中，初潮年龄较早是经前期综合征的危险因素。这一发现可能有助于利益相关者(心理健康政策制定者，管理员,和心理健康专业人员)来解决预防问题，早期筛查,以及育龄妇女经前综合症的管理，并关注更脆弱的身体。
■https://www.crd.约克。AC.英国/PROSPERO,标识符CRD42023414021。
■我们对系统评价和荟萃分析报告使用了适当的指南，这是系统审查和荟萃分析(PRISMA)的首选报告项目。本综述方案在PROSPERO(CRD42023414021)中注册。出版物来自PubMed/Medline，EMBASE,Scopus数据库,和其他灰色搜索。纳入的论文是报告经前综合征患病率和相关因素发表的原始数据，在英语中,和论文可从2000年1月1日至2023年5月30日在线获得。数据是在MicrosoftExcel中提取的，然后将其导入到STATA11.0中进行分析。
■我们纳入了在非洲国家进行的16项研究，有6530名研究参与者。在这个荟萃分析中，非洲育龄期参与者的经前期综合征合并患病率为46.98(95%CI:28.9~65.06%).Further,在亚组分析中，尼日利亚经前期综合征的合并患病率为57.32%，埃塞俄比亚占43.8%，大学生为38.6%，中学生为66.04%。在相关因素中，初潮年龄较早与经前期综合征显著相关。
■在这篇评论中，非洲经前期综合征的合并患病率较高.在因素中，初潮年龄较早是经前期综合征的危险因素。这一发现可能有助于利益相关者(心理健康政策制定者，管理员,和心理健康专业人员)来解决预防问题，早期筛查,以及育龄妇女经前综合症的管理，并关注更脆弱的身体。
■https://www.crd.约克。AC.英国/PROSPERO,标识符CRD42023414021。
